Litcius/Paper detail

Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neck

Khalil Saleh, Anne Aupérin, Nicolas Martin, Édith Borcoman, Nouritza Torossian, Mariana Iacob, François‐Régis Ferrand, Nadine Khalife, Neus Basté, J. Guigay, Christophe Le Tourneau, Amaury Daste, Esma Saâda-Bouzid, Caroline Even

2021European Journal of Cancer19 citationsDOI

Topics & Concepts

MedicineHead and neckBasal cellOncologyHead and neck squamous-cell carcinomaInternal medicineCarcinomaHead and neck cancerDermatologySurgeryCancerHead and Neck Cancer StudiesCancer Immunotherapy and BiomarkersColorectal and Anal Carcinomas
Efficacy and safety of immune checkpoint inhibitors in elderly patients (≥70 years) with squamous cell carcinoma of the head and neck | Litcius